Products
Types of Biomarker
Prognostic biomarker
Predictive biomarker
Precision Medicine Business
| Pipeline | Drug Development | Phase I | Phase II | Phase III | |
|---|---|---|---|---|---|
| Biomarker Development | Single center Validation | Multi-center validation (Global) | |||
| PROGNOSTICS | HCC | OncoHepaTest® | |||
| CRC | PCRT | ||||
| HNSCC | Prognosis | ||||
| TNBC | Prognosis | ||||
| HCC | TACE | ||||
| Liver Fibrosis | Prognosis of progressiveness | ||||
| PREDICTIVE | HCC Nexavar® （ORR） | ||||
| HCC Nexavar® (DCR) | |||||
| TNBC Doxorubicin + Cyclophosphamide | |||||
| HNSCC First line palliative therapy | |||||
| SCLC Keytruda + Taxol | |||||
| PSC IMFINZI + Tremelimumab (Immune therapy) | |||||
| ACC Axitinib | |||||
Biomarker development Business
| Pipeline | Analysis Platform | Platform development | Platform validation | Commercialization |
|---|---|---|---|---|
| Prognostic · Predictive · Precision medicine service | CbsBio AI platform (STATS, MLBS, PINGS) | |||
